Drug intelligence / Profile preview

Grotin

Development stage: Unknown
Lead developer: Grievers Remedies
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

Grotin is a protein supplement brand marketed by Grievers Remedies. The product line includes a standard protein powder formulation and a specialized version, D.Grotin, which is tailored for individuals with diabetes. As a nutritional supplement, Grotin provides essential amino acids and dietary protein to support muscle maintenance, tissue repair, and general metabolic health. The product is manufactured through third-party partnerships and is distributed primarily within the Indian healthcare market as a marketed (approved) nutritional product rather than an R&D-focused therapeutic candidate.

Brand names: GrotinGrotin-Protein PowderD.Grotin
Other names: Grotin-Protein PowderD.Grotin-Protein for Diabetics

Beyond the preview

Go deeper on Grotin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grotin.

Explore the full profile